Postmenopausal hormone therapy and subclinical cerebrovascular disease

Abstract

Conjugated equine estrogen-based hormone therapy was not associated with a significant increase in ischemic brain lesion volume relative to placebo. This finding was consistent within each trial and in pooled analyses across trials.